A developmental model of neuroblastoma: Differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage

Laboratory Investigation

Volumn 75, Issue 5, 1996, Pages 659-675

  Hoehner, Jeff C ^a   Gestblom, Carolina ^a,c   Hedborg, Fredrik ^a   Sandstedt, Bengt ^b   Olsen, Leif ^a   Påhlman, Sven ^a,c,d  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; NEURON SPECIFIC ENOLASE; NEUROPEPTIDE Y; PHENYLETHANOLAMINE N METHYLTRANSFERASE; PROTEIN BCL 2; SOMATOMEDIN B;

ARTICLE; CHILD; CHROMAFFIN CELL; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; FETUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFANT; NEUROBLASTOMA; NEWBORN; PRIORITY JOURNAL; SYMPATHETIC GANGLION; TUMOR DIFFERENTIATION;

ANTIGENS, CD44; CELL DIFFERENTIATION; CHILD, PRESCHOOL; EMBRYONIC AND FETAL DEVELOPMENT; FETUS; HUMANS; INFANT; MODELS, BIOLOGICAL; NEUROBLASTOMA; PHOSPHOPYRUVATE HYDRATASE; PROTO-ONCOGENE PROTEINS C-BCL-2; SYMPATHETIC NERVOUS SYSTEM; TUMOR MARKERS, BIOLOGICAL; TYROSINE 3-MONOOXYGENASE;

EID: 0029852033     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Adams GA, Shochat SJ, Smith EI, Shuster JJ, Joshi VV, Altshuler G, Hayes FA, Nitschke R, McWilliams N, and Castleberry RP (1993). Thoracic neuroblastoma: A Pediatric Oncology Group study. J Pediatr Surg 28:372-378.
2. Ambros IM and Ambros PF (1995). Schwann cells in neuroblastoma. Eur J Cancer 31A:429-434.
3. Ambros IM, Zellner A, Stock C, Amann G, Gadner H, and Ambros PF (1994). Proof of the reactive nature of the Schwann cell in neuroblastoma and its clinical implications. Adv Neuroblastoma Res 4:331-337.
4. Beckwith JB and Martin R (1968). Observations on the histologic theory of neuroblastomas. J Pediatr Surg 3:106-110.
5. Beckwith JB and Perrin E (1962). In situ neuroblastomas: A contribution to the natural history of neural crest tumors. Am J Pathol 43:1089-1104.
6. Biegel JA, White PS, Marshall HN, Fujimori M, Zackai EH, Scher CD, Brodeur GM, and Emanuel BS (1993). Constitutional 1p36 deletion in a child with neuroblastoma. Am J Hum Genet 52:176-182.
7. Borrello MG, Bongarzone I, Pierotti MA, Luksch R, Gasparini M, Collini P, Pilotti S, Rizzetti MG, Mondellini P, DeBernardi B, DiMartino D, Garaventa A, Brisigotti M, and Tonini GP (1993). trk and ret protooncogene expression in human neuroblastoma specimens: High frequency of trk expression in non-advanced stages. Int J Cancer 54:540-545.
8. Brodeur GM (1990). Molecular biology and genetics of human neuroblastoma. In: Pochedly C, editor. Neuroblastoma: Tumor biology and therapy. Boca Raton, FL: CRC Press, 31-50.
9. Brodeur GM, Fong CT, Morita M, Griffith R, Hayes FD, and Seeger RC (1988). Molecular analysis and clinical significance of N-myc amplification and chromosome 1p monosomy in human neuroblastomas. Prog Clin Biol Res 271:3-15.
10. Brodeur GM, Pritchard J, Berthold F, Carlsen N, Castel V, Castleberry R, DeBernardi B, Evans A, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lamport F, Lee R, Look T, Pearson A, Philip T, Roald B, Sawada T, Seeger R, Tsuchida Y, and Voute P (1993). Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466-1477.
11. Brundin T (1966). Studies on the preaortic paraganglia of newborn rabbits. Acta Physiol Scand 70(Suppl 290): 1-54.
12. Ciccarone V, Spengler BA, Meyers MB, Biedler JL, and Ross RA (1989). Phenotypic diversification in human neuroblastoma cells: Expression of distinct neural crest lineages. Cancer Res 49:219-225.
13. Coldman AJ, Fryer CJH, Elwood JM, and Sonley MJ (1980). Neuroblastoma: Influence of age at diagnosis, stage, tumor site and sex on prognosis. Cancer 46:1896-1901.
14. Cooper MJ, Hutchins GM, Cohen PS, Helman LJ, Mennie RJ, and Israel MA (1990a). Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts. Cell Growth Differ 1:149-159.
15. Cooper MJ, Hutchins GM, and Israel MA (1990b). Histogenesis of the human adrenal medulla: An evaluation of the ontogeny of chromaffin and nonchromaffin lineages. Am J Pathol 137:605-615.
16. Cooper MJ, Steinberg SM, Chatten J, Evans AE, and Israel MA (1992). Plasticity of neuroblastoma tumor cells to differentiate along a fetal adrenal ganglionic lineage predicts for improved patient survival. J Clin Invest 90:2402-2408.
17. Coupland R (1980). The development and fate of catecholamine secreting endocrine cells. In: Parvis H and Parvis S, editors. Biogenic amines in development. Amsterdam: Elsevier/North-Holland, 3-28.
18. Coupland R (1965). The natural history of the chromaffin cell. London: Longmans Green.
19. Coupland R (1952). The prenatal development of the abdominal para-aortic bodies in man. J Anat 86:357-372.
20. D'Angio G, Evans AE, and Koop CE (1971). Special pattern of wide-spread neuroblastoma with a favourable prognosis. Lancet 1:1046-1049.
21. Dixon JS, Gosling JA, Canning DA, and Gearhart JP (1992). An immunohistochemical study of human postnatal paraganglia associated with the urinary bladder. J Anat 181:431-436.
22. Doupe J, Patterson H, and Landis S (1985). Small intensely fluorescent cells in culture: Role of glucocorticoids and growth factors in their development and interconversions with other neural crest derivatives. J Neurosci 5:2143-2160.
23. Elfvin LG, Hokfelt T, and Goldstein M (1975). Fluorescence microscopical, immunohistochemical and ultrastructure studies on sympathetic ganglia of the guinea pig, with special reference to the SIF cells and their catecholamine content. J Ultrastructure Res 51:377-396.
24. Evans AE, Albo V, and D'Angio GJ (1976a). Factors influencing survival of children with nonmetastatic neuroblastoma. Cancer 38:661-666.
25. Evans AE, D'Angio GJ, Propert K, Anderson J, and Hann H-W (1987). Prognostic factors in neuroblastoma. Cancer 59:1853-1859.
26. Evans AE, D'Angio GJ, and Randolph JA (1971). A proposed staging for children with neuroblastoma. Cancer 27:374-378.
27. Evans AE, Gerson J, Schnaufer L (1976b). Spontaneous regression of neuroblastoma. Natl Cancer Inst Monogr 44: 49-55.
28. Everson T and Cole W (1966). Spontaneous regression of cancer. Philadelphia: WB Saunders.
29. Gestblom C, Hoehner JC, and Påhlman S (1995). Proliferation and apoptosis in neuroblastoma: Subdividing the mitosis-karyorrhexis index. Eur J Cancer 31A:458-463.
30. Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D, and Beck D (1994). CD44H expression by human neuroblastoma cells: Relation to MYCN amplification and lineage differentiation. Cancer Res 54:4238-4242.
31. Hedborg F, Bjelfman C, Sparen P, Sandstedt B, and Påhlman S (1995a). Biochemical evidence for a mature phenotype in morphologically poorly differentiated neuroblastomas with favourable outcome. Eur J Cancer 31A:435-443.
32. Hedborg F, Ohlsson R, Sandstedt B, Grimelius L, Hoehner JC, and Påhlman S (1995b). IGF-2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma. Am J Pathol 146:833-847.
33. Hervonen A and Korkala O (1972). The effect of hypoxia on the catecholamine content of human fetal abdominal paraganglia and adrenal medulla. Acta Obstet Gynecol Scand 51:17-24.
34. Hoehner JC, Hedborg F, Sandstedt B, Olsen L, and Påhlman S (1995a). Cellular death in neuroblastoma: In situ correlation of apoptosis and Bcl-2 expression. Int J Cancer 62:19-24.
35. Hoehner JC, Olsen L, Sandstedt B, Kaplan DR, and Påhlman S (1995b). Association of neurotrophin receptor expression and differentiation in human neuroblastoma. Am J Pathol 147:102-113.
36. Joshi W, Cantor AB, Altshuler G, Larkin EW, Neill JSA, Shuster JJ, Holbrook CT, Hayes FA, and Castleberry RP (1992a). Recommendations for modifications of terminology of neuroblastic tumors and prognostic significance of Shimada classification. Cancer 69:2183-2196.
37. Joshi VV, Cantor AB, Altshuler G, Larkin EW, Neill JS, Shuster JJ, Holbrook CT, Hayes FA, Nitschke R, and Duncan MH. (1992b). Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas: A clinico-pathologic study of 211 cases from the Pediatric Oncology Group. Cancer 69:2197-2209.
38. Joshi VV, Chatten J, Sather HN, and Shimada H (1991). Evaluation of the Shimada classification in advanced neuroblastoma with special reference to the mitosis-karyorrhexis index: A report from the Children's Cancer Study Group. Mod Pathol 4:139-147.
39. Kinnier Wilson LM and Draper GJ (1974). Neuroblastoma, its natural history and prognosis: A study of 487 cases. Br Med J 3:301-307.
40. Kogner P, Barbany G, Dominici C, Castello M, Raschella G, and Persson H (1993). Coexpression of mRNA for trk protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res 53: 2044-2050.
41. Krajewski S, Chatten J, Hanada M, and Reed JC (1995). Immunohistochemical analysis of the bcl-2 oncoprotein in human neuroblastomas: Comparisons with tumor cell differentiation and N-Myc protein. Lab Invest 71:42-52.
42. Laug WE, Siegel SE, Shaw KN, Landing B, Baptista J, and Gutenstein M (1978). Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma. Pediatrics 62:77-83.
43. Lloyd RV, Sisson JC, Shapiro B, and Verhofstad AAJ (1986). Immunohistochemical localization of epinephrine, norepinephrine, catecholamine-synthesizing enzymes, and chromogranin in neuroendocrine cells and tumors. Am J Pathol 125:45-54.
44. Molenaar WM, Baker DL, Pleasure D, Lee VM, and Trojanowski JQ (1990a). The neuroendocrine and neural profiles of neuroblastomas, ganglioneuroblastomas, and ganglioneuromas. Am J Pathol 136:375-382.
45. Molenaar WM, Lee VM-Y, and Trojanowski JQ (1990b). Early fetal acquisition of the chromaffin and neuronal immunophenotype by human adrenal medullary cells: An immunohistological study using monoclonal antibodies to chromogranin A, synaptophysin, tyrosine hydroxylase, and neuronal cytoskeletal proteins. Exp Neurol 108:1-9.
46. Morris JA, Shochat SJ, Smith EI, Look AT, Brodeur GM, Cantor AB, and Castleberry RP (1995). Biological variables in thoracic neuroblastoma: A pediatric oncology group study. J Pediatr Surg 30:296-303.
47. Murphy S, Cohn S, Craft A, Woods W, Sawada T, Castleberry R, Levy H, Prorok P, and Hammond G (1991). Do children benefit from mass screening for neuroblastoma? Consensus statement from the American Cancer Society Workshop on Neuroblastoma Screening. Lancet 337:344-346.
48. Nakagawara A, Asima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, and Brodeur GM (1993). Association between high levels of expression of the trk gene and favorable outcome in human neuroblastoma. N Engl J Med 328:847-854.
49. Nitschke R, Smith E, and Shochat S (1988). Localized neuroblastoma treated by surgery: A Pediatric Oncology Group study. J Clin Oncol 6:1271-1278.
50. Örtoft E, Bjelfman C, Hedborg F, Grimelius L, and Påhlman S (1995). The expression profile of alternatively spliced neuronal c-src RNA distinguishes between human tumours of the sympatho-adrenal lineage. Int J Cancer 60:38-44.
51. Påhlman S, Hoehner JC, Nånberg E, Hedborg F, Fagerstr''m S, Gestblom C, Johansson I, Larsson U, Lavenius E, Örtoft E, and S''derholm H (1995). Differentiation and survival influences of growth factors in human neuroblastoma. Eur J Cancer 31A:453-458.
52. Qualman SJ, O'Dorisio MS, Fleshman DJ, Shimada H, and O'Dorisio TM (1992). Neuroblastoma: Correlation of neuropeptide expression in tumor tissue with other prognostic factors. Cancer 70:2005-2012.
53. Sandstedt B, Jereb B, and Eklund G (1983). Prognostic factors in neuroblastoma. Acta Pathol Microbiol Immunol Scand Sect A 91:365-371.
54. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, and Hammond D (1985). Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116.
55. Shimada H, Aoyama C, Chiba T, and Newton WAJ (1985). Prognostic subgroups for undifferentiated neuroblastoma: Immunohistochemical study with anti-S-100 protein antibody. Hum Pathol 16:471-476.
56. Shimada H, Chatten J, Newton WA, Sachs N, Hamoudi A, Chiba T, Marsden H, and Misugi K (1984). Histopathologic prognostic factors in neuroblastoma tumors: Definition of subtypes of ganglioneuroblastoma and an age linked classification of neuroblastoma. J Natl Cancer Inst 73:405-416.
57. Suzuki T, Bogenmann E, Shimada H, Stram D, and Seeger RC (1993). Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst 85:377-384.
58. Terpe H-J, Christiansen H, Gonzalez M, Berthold F, and Lampert F (1995). Differentiation and prognosis of neuroblastoma in correlation to the expression of CD44s. Eur J Cancer 31A:549-552.
59. Thiele CJ (1991). Biology of pediatric peripheral neuroectodermal tumors. Cancer Metastasis Rev 10:311-319.
60. Tischler A (1991). The adrenal medulla and extra-adrenal paraganglia. In: Kovacs K and Asa S, editors. Functional endocrine pathology. St. Louis, MO: Blackwell Scientific, 509-545.
61. Tsokos M, Scarpa S, Ross RA, and Triche TJ (1987). Differentiation of human neuroblastoma recapitulates neural crest development: Study of morphology, neurotransmitter enzymes, and extracellular matrix proteins. Am J Pathol 128: 484-496.
62. Turkel SB and Itabashi HH (1974). The natural history of neuroblastic cells in the fetal adrenal gland. Am J Pathol 76:225-244.
63. Zuckerkandl E (1912). The development of the chromaffin organs and the suprarenal glands in human embryology. Philadelphia: Lippincott, 157-179.